Synaptogyrin-2 inhibitors belong to a specific class of chemical compounds that have garnered interest in the field of neuroscience and synaptic vesicle trafficking. Synaptogyrin-2 is a transmembrane protein predominantly found in neurons, specifically within synaptic vesicles and endosomes. It plays a crucial role in regulating various processes associated with synaptic vesicle dynamics, such as vesicle biogenesis, recycling, and fusion at the synapse. Synaptic vesicles are essential for the transmission of neurotransmitters across synapses, facilitating communication between neurons. Synaptogyrin-2 inhibitors are chemical compounds designed to interact with Synaptogyrin-2, potentially influencing its role in regulating synaptic vesicle trafficking and neurotransmitter release.
The mechanism of action of Synaptogyrin-2 inhibitors typically involves their binding to specific regions or domains within the Synaptogyrin-2 protein. This interaction can lead to changes in Synaptogyrin-2's ability to participate in synaptic vesicle trafficking, potentially affecting processes like vesicle biogenesis or fusion with the presynaptic membrane. Consequently, Synaptogyrin-2 inhibitors may have implications for the dynamics of neurotransmitter release, impacting neuronal communication and synaptic plasticity. The study of Synaptogyrin-2 inhibitors is instrumental in advancing our understanding of the molecular mechanisms governing synaptic vesicle trafficking, offering insights into the intricate regulatory networks that underlie neurotransmission and synaptic function. Additionally, it contributes to the broader field of neurobiology and neurophysiology research, providing valuable tools for investigating the roles of Synaptogyrin-2 in various neuronal contexts and its impact on synaptic signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, preventing RNA synthesis by inhibiting RNA polymerase, which could reduce Synaptogyrin-2 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin targets RNA polymerase II, which is critical for mRNA synthesis, and could thereby decrease Synaptogyrin-2 mRNA levels. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin, a nucleoside analog, terminates mRNA elongation and could thus inhibit Synaptogyrin-2 mRNA production. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis by interfering with the translocation step on ribosomes, which might reduce Synaptogyrin-2 levels. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates into DNA and interferes with topoisomerase II, leading to effects on transcription and possibly on Synaptogyrin-2 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits DNA topoisomerase II, leading to DNA damage and potentially affecting Synaptogyrin-2 gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA, inhibiting RNA polymerase and thus potentially decreasing Synaptogyrin-2 production. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin causes premature chain termination during translation, which could indirectly affect Synaptogyrin-2 protein synthesis. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin binds to RNA polymerase, inhibiting RNA synthesis, which may lead to a decrease in Synaptogyrin-2 mRNA levels. | ||||||
Streptozotocin (U-9889) | 18883-66-4 | sc-200719 sc-200719A | 1 g 5 g | $116.00 $530.00 | 152 | |
Streptozotocin causes DNA alkylation and damage, which can result in a general reduction of gene expression, including Synaptogyrin-2. | ||||||